Kariburyo Furaha, Wang Yuexi, Cheng I-Ning Elaine, Wang Lisa, Morgenstern David, Xie Lin, Meadows Eric, Danella John, Cher Michael L
STATinMED Research, 211 N. Fourth Avenue, Suite 2B, Ann Arbor, MI, 48104, USA.
Diagnostics Information Solutions, F. Hoffmann-La Roche AG, Basel, Switzerland.
BMC Urol. 2018 Jun 4;18(1):55. doi: 10.1186/s12894-018-0372-1.
The objective of this study was to describe overall survival and the management of men with favorable risk prostate cancer (PCa) within a large community-based health care system in the United States.
A retrospective cohort study was conducted using linked electronic health records from men aged ≥40 years with favorable risk PCa (T1 or 2, PSA ≤15, Gleason ≤7 [3 + 4]) diagnosed between January 2005 and October 2013. Cohorts were defined as receiving any treatment (IMT) or no treatment (OBS) within 6 months after index PCa diagnosis. Cohorts' characteristics were compared between OBS and IMT; monitoring patterns were reported for OBS within the first 18 and 24 months. Cox Proportional Hazards models were used for multivariate analysis of overall survival.
A total of 1425 men met the inclusion criteria (OBS 362; IMT 1063). The proportion of men managed with OBS increased from 20% (2005) to 35% (2013). The OBS group was older (65.6 vs 62.8 years, p < 0.01), had higher Charlson comorbidity index scores (CCI ≥2, 21.5% vs 12.2%, p < 0.01), and had a higher proportion of low-risk PCa (65.2% vs 55.0%, p < 0.01). For the OBS cohort, 181 of the men (50%) eventually received treatment. Among those remaining on OBS for ≥24 months (N = 166), 88.6% had ≥1 follow-up PSA test and 26.5% received ≥1 follow-up biopsy within the 24 months. The unadjusted mortality rate was higher for OBS compared with IMT (2.7 vs 1.3/100 person-years [py]; p < 0.001). After multivariate adjustment, there was no significant difference in all-cause mortality between OBS and IMT groups (HR 0.73, p = 0.138).
Use of OBS management increased over the 10-year study period. Men in the OBS cohort had a higher proportion of low-risk PCa. No differences were observed in overall survival between the two groups after adjustment of covariates. These data provide insights into how favorable risk PCa was managed in a community setting.
本研究的目的是描述美国一个大型社区医疗保健系统中低危前列腺癌(PCa)男性患者的总生存期及治疗情况。
进行一项回顾性队列研究,使用2005年1月至2013年10月期间诊断为低危PCa(T1或2期,PSA≤15,Gleason评分≤7[3+4])且年龄≥40岁男性的关联电子健康记录。队列定义为在首次PCa诊断后6个月内接受任何治疗(IMT)或未接受治疗(OBS)。比较OBS组和IMT组的队列特征;报告OBS组在最初18个月和24个月内的监测模式。采用Cox比例风险模型对总生存期进行多因素分析。
共有1425名男性符合纳入标准(OBS组362例;IMT组1063例)。采用OBS治疗的男性比例从2005年的20%增至2013年的35%。OBS组患者年龄更大(65.6岁对62.8岁,p<0.01),Charlson合并症指数评分更高(CCI≥2,21.5%对12.2%,p<0.01),低危PCa比例更高(65.2%对55.0%,p<0.01)。对于OBS队列,181名男性(50%)最终接受了治疗。在持续OBS治疗≥24个月的患者中(N=166),88.6%在24个月内进行了≥1次随访PSA检测,26.5%接受了≥1次随访活检。OBS组的未调整死亡率高于IMT组(2.7对1.3/100人年[py];p<0.001)。多因素调整后,OBS组和IMT组的全因死亡率无显著差异(HR 0.73,p=0.138)。
在10年研究期间,采用OBS治疗的情况有所增加。OBS队列中的男性低危PCa比例更高。调整协变量后,两组的总生存期无差异。这些数据为社区环境中低危PCa的治疗提供了见解。